Physician scientist and oncologist in training Dr. Amira Barkal discusses her extraordinary journey commercializing scientific discoveries she made with Dr. Irving Weissman during MD/PhD at Stanford. Barkal went on to raise $76M as founder and CEO of Pheast Therapeutics, all while completing her residency at Brigham and Women's Hospital. Join for a conversation around finding courage to start a company as a scientific founder, navigating being a founder CEO, and operating a biotech startup during clinical training.